| Original Research Online Publishing Date: | ||||||||||||
The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study Suchibrata Das, Sangita Patra, Saikat Banerjee, Alok Kumar Roy.
| ||||||||||||
| How to Cite this Article |
| Pubmed Style Das S, Patra S, Banerjee S, Roy AK. The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study. Natl J Physiol Pharm Pharmacol. 2023; 13(12): 2433-2439. doi:10.5455/njppp.2023.13.04171202312052023 Web Style Das S, Patra S, Banerjee S, Roy AK. The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study. https://www.njppp.com/?mno=148286 [Access: March 15, 2024]. doi:10.5455/njppp.2023.13.04171202312052023 AMA (American Medical Association) Style Das S, Patra S, Banerjee S, Roy AK. The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study. Natl J Physiol Pharm Pharmacol. 2023; 13(12): 2433-2439. doi:10.5455/njppp.2023.13.04171202312052023 Vancouver/ICMJE Style Das S, Patra S, Banerjee S, Roy AK. The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study. Natl J Physiol Pharm Pharmacol. (2023), [cited March 15, 2024]; 13(12): 2433-2439. doi:10.5455/njppp.2023.13.04171202312052023 Harvard Style Das, S., Patra, . S., Banerjee, . S. & Roy, . A. K. (2023) The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study. Natl J Physiol Pharm Pharmacol, 13 (12), 2433-2439. doi:10.5455/njppp.2023.13.04171202312052023 Turabian Style Das, Suchibrata, Sangita Patra, Saikat Banerjee, and Alok Kumar Roy. 2023. The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study. National Journal of Physiology, Pharmacy and Pharmacology, 13 (12), 2433-2439. doi:10.5455/njppp.2023.13.04171202312052023 Chicago Style Das, Suchibrata, Sangita Patra, Saikat Banerjee, and Alok Kumar Roy. "The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 2433-2439. doi:10.5455/njppp.2023.13.04171202312052023 MLA (The Modern Language Association) Style Das, Suchibrata, Sangita Patra, Saikat Banerjee, and Alok Kumar Roy. "The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study." National Journal of Physiology, Pharmacy and Pharmacology 13.12 (2023), 2433-2439. Print. doi:10.5455/njppp.2023.13.04171202312052023 APA (American Psychological Association) Style Das, S., Patra, . S., Banerjee, . S. & Roy, . A. K. (2023) The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study. National Journal of Physiology, Pharmacy and Pharmacology, 13 (12), 2433-2439. doi:10.5455/njppp.2023.13.04171202312052023 |
